Factors associated with development and distribution of granular/fuzzy astrocytes in neurodegenerative diseases. (6th May 2020)

• Record Type: Journal Article
• Authors: Miki, Tomoko; Yokota, Osamu; Haraguchi, Takashi; Ishizu, Hideki; Hasegawa, Masato; Ishihara, Takeshi; Ueno, Shu‐ichi; Takenoshita, Shintaro; Terada, Seishi; Yamada, Norihito
• Is Part Of: Brain pathology. Volume 30:Number 4(2020)
• Page Start: 811
• Page End: 830
• Publication Date: 2020-05-06
• Subjects: aging‐related tau astrogliopathy -- argyrophilic grain -- granular/fuzzy astrocyte -- primary age‐related tauopathy -- tau -- tufted astrocyte; Nervous system -- Diseases -- Periodicals; Brain -- Diseases -- Periodicals; Neurology -- Periodicals; Brain Diseases -- Periodicals; Cerveau -- Maladies -- Périodiques; Système nerveux -- Maladies -- Périodiques; Neurologie -- Périodiques; 616.805
• DOI: 10.1111/bpa.12843
• Languages: English
• ISSNs: 1015-6305

Abstract

Abstract: Granular/fuzzy astrocytes (GFAs), a subtype of "aging‐related tau astrogliopathy, " are noted in cases bearing various neurodegenerative diseases. However, the pathogenic significance of GFAs remains unclear. We immunohistochemically examined the frontal cortex, caudate nucleus, putamen and amygdala in 105 cases composed of argyrophilic grain disease cases (AGD, N = 26), and progressive supranuclear palsy (PSP, N = 10), Alzheimer's disease (AD, N = 20) and primary age‐related tauopathy cases (PART, N = 18) lacking AGD, as well as 31 cases bearing other various neurodegenerative diseases to clarify (i) the distribution patterns of GFAs in AGD, and PSP, AD and PART lacking AGD, (ii) the impacts of major pathological factors and age on GFA formation and (iii) immunohistochemical features useful to understand the formation process of GFAs. In AGD cases, GFAs consistently occurred in the amygdala (100%), followed by the putamen (69.2%) and caudate nucleus and frontal cortex (57.7%, respectively). In PSP cases without AGD, GFAs were almost consistently noted in all regions examined (90–100%). In AD cases without AGD, GFAs were less frequent, developing preferably in the putamen (35.0%) and caudate nucleus (30.0%). PART cases without AGD had GFAs most frequently in the amygdala (35.3%), being more similar to AGD than to AD cases. Ordered logistic regression analyses using all cases demonstrated that the strongest independent factor of GFA formation in the frontal cortex and striatum was the diagnosis of PSP, while that in the amygdala was AGD. The age was not significantly associated with GFA formation in any region. In GFAs in AGD cases, phosphorylation and conformational change of tau, Gallyas‐positive glial threads indistinguishable from those in tufted astrocytes, and the activation of autophagy occurred sequentially. Given these findings, AGD, PSP, AD and PART cases may show distinct distributions of GFAs, which may provide clues to predict the underlying processes of primary tauopathies.